Fever
- PMID: 9208885
Fever
Abstract
Measurement of body temperature is the most common clinical test performed. The presence of fever is accepted as a reliable indicator of either acute of chronic disease. Although the vast majority of fevers are caused by infectious agents, some solid tumors have fever as a presenting illness usually because of associated inflammation or infection secondary to the neoplasm. However, cancer cells can spontaneously produce cytokines, small proteins with multiple biological properties. Some cytokines released by neoplastic cells are pyrogenic, ie, they produce fever directly by their action on the hypothalamic thermoregulatory center. Examples of malignant cells producing pyrogenic cytokines are renal carcinoma, lymphomas, and acute myelogenous and chronic myelogenous leukemias. The pyrogenic cytokines released by these cancers are interleukin-6, interleukin-1, tumor necrosis factor, and interferon, but others likely exist. Antipyretics reduce fever regardless of its causation; some studies suggest that fever caused by pyrogenic cytokines released from malignancies is preferentially reduced by nonsteroidal anti-inflammatory agents.
Similar articles
-
Fever of unknown origin (FUO) caused by multiple myeloma: the diagnostic value of the Naprosyn test.Heart Lung. 2006 Sep-Oct;35(5):358-62. doi: 10.1016/j.hrtlng.2005.10.001. Heart Lung. 2006. PMID: 16963369
-
Diagnostic implications and clinical consequences of antipyretic therapy.Clin Infect Dis. 2000 Oct;31 Suppl 5:S230-3. doi: 10.1086/317512. Clin Infect Dis. 2000. PMID: 11113028 Review.
-
How to differentiate neoplastic fever from infectious fever in patients with cancer: usefulness of the naproxen test.Heart Lung. 1987 Mar;16(2):122-7. Heart Lung. 1987. PMID: 3028981 No abstract available.
-
Pathophysiology and management of fever.J Support Oncol. 2006 Jan;4(1):9-16. J Support Oncol. 2006. PMID: 16444847 Review.
-
Antipyretic effect of cycloheximide, and inhibitor of protein synthesis, in patients with Hodgkin's disease or other malignant neoplasms.Cancer Res. 1975 May;35(5):1218-24. Cancer Res. 1975. PMID: 1091349
Cited by
-
Cyclo-oxygenase II inhibitors in the treatment of neoplastic fever.Support Care Cancer. 2003 Apr;11(4):258-9. doi: 10.1007/s00520-002-0432-6. Epub 2003 Mar 1. Support Care Cancer. 2003. PMID: 12673465 Clinical Trial.
-
Pancreatic carcinoma masked as fever of unknown origin: A case report and comprehensive review of literature.Medicine (Baltimore). 2016 Aug;95(35):e4643. doi: 10.1097/MD.0000000000004643. Medicine (Baltimore). 2016. PMID: 27583884 Free PMC article. Review.
-
Neoplastic fever in patients with bone and soft tissue sarcoma.Mol Clin Oncol. 2016 Nov;5(5):631-634. doi: 10.3892/mco.2016.1027. Epub 2016 Sep 21. Mol Clin Oncol. 2016. PMID: 27900101 Free PMC article.
-
Hodgkin Lymphoma Presenting as Pel-Ebstein Fever: A Case Report.Cancer Rep (Hoboken). 2024 Nov;7(11):e70039. doi: 10.1002/cnr2.70039. Cancer Rep (Hoboken). 2024. PMID: 39566932 Free PMC article.
-
Neoplastic fever: a neglected paraneoplastic syndrome.Support Care Cancer. 2005 Nov;13(11):870-7. doi: 10.1007/s00520-005-0825-4. Epub 2005 Apr 29. Support Care Cancer. 2005. PMID: 15864658 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical